South Australian feature: The engine driver
21 May, 2002 by Pete YoungDr Jurgen Michaelis is the man in the hot seat at Bio Innovation SA, the State government's engine of choice for accelerating growth of a commercial bioscience sector.
South Australian feature: How a 15-minute city bred a biohub
21 May, 2002 by Tanya HollisIf Adelaide is the city of churches, there can be no doubt that its suburb Thebarton is the borough of biotechs.
R&D Start grant woes backdated
20 May, 2002 by Daniella GoldbergThe writing was on the wall for the suspension of the Commonwealth government's R&D Start program as early as January, Australian Biotechnology News has learned.
Anderson joins PM's science council
20 May, 2002 by Tanya HollisDeputy prime minister and avowed embryonic stem cell research opponent John Anderson has been granted a seat on the government's peak science and innovation council.
Second Autogen director resigns
17 May, 2002 by Tanya HollisTwo weeks after former Prime Minister Bob Hawke resigned from the board of Autogen, a second director has resigned, citing other business commitments.
Tasmanian feature: Tasmanian Tigers
17 May, 2002 by Tanya Hollis and Melissa TrudingerTasmania might be the smallest Australian state, but it has some advantages for the biotechnology industry that the other states can't even dream of.
FASTS to lobby on science education
17 May, 2002 by Daniella GoldbergAustralia's peak council for science and technology has called for a 10-year plan to develop and improve the national education system.
Vic govt pledges support for bio conference
16 May, 2002 by Tanya HollisVictoria's government has pledged up to $55,000 in sponsoring industry group AusBiotech's major conference in August.
Victorian feature: Investment Issues
16 May, 2002 by Tanya HollisFinance and funding issues affecting the biotechnology industry appear to be something of a chicken and egg scenario.
Victorian feature: Vic bio warns against early IPO
16 May, 2002 by Tanya Hollis and Melissa TrudingerHad Amrad Corporation been conceived in the United States it would only now be considering a public listing, according to its managing director.
Budget holds no surprises for academics
15 May, 2002 by Melissa TrudingerThe Australian Vice-Chancellor's Committee has adopted a wait-and-see attitude following last night's Federal budget.
Nothing new for science in Fed budget
15 May, 2002 by Daniella GoldbergPouring millions into defence and border security, with cuts in health and welfare, this year's Federal budget carries no significant investment for science and technology.
Milestone payments for Peptech's D2E7
14 May, 2002 by Daniella GoldbergPeptech has received its first milestone payment from its agreement with Abbott Laboratories to market the rheumatoid arthritis drug D2E7.
Biotech festival begins with call for science teachers
14 May, 2002 by Tanya HollisVictoria's week-long festival of biotechnology education kicked off last night (May 13) with a call for more specially trained teachers.
Analysing venture capital
13 May, 2002 by Daniella GoldbergVenture capitalists need to be as a good at analysing their clients as any psychiatrist, says Dr Mike Hirshorn, a medical doctor turned venture capitalist, now with Sydney-based VC Nanyang Ventures.
